Cisteo Medical has been acquired by Agôn Electronics, enhancing its capacity to innovate in the growing MedTech sector.
Information on the Target
Cisteo Medical, a leading French company specializing in active medical implants, has recently joined the Agôn Electronics industrial group. Founded in 2010 in the microtechnology hub of Besançon, Cisteo Medical has established itself as a key player in the design, manufacture, and approval of complex medical devices, including active implants. The company is renowned for its high-value products such as neurostimulators, pacemakers, medical electrodes, and reconstruction devices. As of November 13, 2024, Cisteo Medical has completed the sale of 100% of its shares to Agôn Electronics, with the transaction expected to finalize by the end of 2025.
This partnership establishes a vital step forward for Cisteo Medical, providing it with the necessary resources to enhance its industrial capabilities amid a highly competitive international market and increasing regulatory demands. With a workforce of 60 employees and a projected revenue of 5 million euros for 2025, the company is set to grow under the umbrella of a larger entity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The medical device sector remains one of the most promising areas within the global healthcare landscape. Currently valued at approximately $681.57 billion, the market for medical devices is projected to reach $955.49 bil
Similar Deals
Siemens Healthineers → Diagnostic division of Novartis’ Advanced Accelerator Applications (AAA)
2024
Agôn Electronics
invested in
Cisteo Medical
in 2024
in a Merger deal
Disclosed details
Revenue: $5M